HNRNPA1 and bladder transitional cell carcinoma: Functional assays revealed that either genetic knockout of HNRNPA1 or substitution of K350 with arginine (K350R) markedly suppressed both the malignant phenotypes and the aerobic glycolysis in BLCA, in vitro and in vivo.